These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21283402)

  • 1. Rational Choice of Antiemetic Agents during Cancer Chemotherapy.
    Brigden ML; Wilson KS; Barnett JB
    Can Fam Physician; 1983 Sep; 29():1682-6. PubMed ID: 21283402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials with antiemetic agents in cancer patients receiving chemotherapy.
    Penta JS; Poster DS; Bruno S; Macdonald JS
    J Clin Pharmacol; 1981; 21(S1):11S-22S. PubMed ID: 6271815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimum management of nausea and vomiting in cancer chemotherapy.
    Triozzi PL; Laszlo J
    Drugs; 1987 Jul; 34(1):136-49. PubMed ID: 3308410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens.
    Grunberg SM
    Blood Rev; 1989 Dec; 3(4):216-21. PubMed ID: 2692744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of cancer chemotherapy-induced nausea and vomiting.
    Eyre HJ; Ward JH
    Cancer; 1984 Dec; 54(11 Suppl):2642-8. PubMed ID: 6498755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The control of cancer chemotherapy-induced nausea and vomiting.
    Dodds LJ
    J Clin Hosp Pharm; 1985 Jun; 10(2):143-66. PubMed ID: 2862166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic optimisation of antiemetic therapy.
    Campbell M; Bateman DN
    Clin Pharmacokinet; 1992 Aug; 23(2):147-60. PubMed ID: 1355018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation.
    Strum SB; McDermed JE; Pileggi J; Riech LP; Whitaker H
    Cancer; 1984 Mar; 53(6):1432-9. PubMed ID: 6692333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of antiemetic use in children with cancer.
    van Hoff J; Hockenberry-Eaton MJ; Patterson K; Hutter JJ
    Am J Dis Child; 1991 Jul; 145(7):773-8. PubMed ID: 2058609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer therapy, vomiting, and antiemetics.
    Stewart DJ
    Can J Physiol Pharmacol; 1990 Feb; 68(2):304-13. PubMed ID: 2178754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nausea and vomiting as major complications of cancer chemotherapy.
    Laszlo J
    Drugs; 1983 Feb; 25 Suppl 1():1-7. PubMed ID: 6840017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.
    Plosker GL; Milne RJ
    Pharmacoeconomics; 1992 Oct; 2(4):285-304. PubMed ID: 10147044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that influence the antiemetic activity of metoclopramide to cisplatin based chemotherapy.
    Tsavaris N; Mylonakis N; Bacoyiannis C; Kosmas C; Kalergis G; Iakovidis V; Tzaninis D; Kosmidis P
    Oncol Rep; 1998; 5(5):1147-55. PubMed ID: 9683826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic management of nausea and vomiting.
    Marin J; Ibañez MC; Arribas S
    Gen Pharmacol; 1990; 21(1):1-10. PubMed ID: 2404830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antiemetic activity of chloropromazine and high doses of metoclopramide in cisplatin-based chemotherapy.
    Tsavaris NB; Papaioannou D; Beldecos D; Kakoliris S; Mylonakis N; Karvounis N; Komitsopoulou P; Karagiaouris P; Sarmas J; Tzannou I
    Acta Oncol; 1990; 29(8):1005-9. PubMed ID: 2278720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiemetic therapy.
    Axelrod RS
    Compr Ther; 1997 Aug; 23(8):539-45. PubMed ID: 9283743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chemotherapy-induced nausea and vomiting.
    Tortorice PV; O'Connell MB
    Pharmacotherapy; 1990; 10(2):129-45. PubMed ID: 2190193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
    Goodman M
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.